April 4, 2023 03:22 PM EDT
Pharma
Marketing

J&J’s Janssen takes doc­tors ‘be­yond the text­book’ to teach about pso­ri­a­sis in peo­ple of col­or

Beth Snyder Bulik

Senior Editor

John­son & John­son’s Janssen is tack­ling health in­equity in pso­ri­a­sis with a new dig­i­tal text­book. Aimed at der­ma­tol­o­gists, rheuma­tol­o­gists (who see re­lat­ed cas­es of pso­ri­at­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times